Advertisement

Topics

Amgen Company Profile

21:10 EST 19th November 2017 | BioPortfolio

The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.


News Articles [516 Associated News Articles listed on BioPortfolio]

Amgen Spain: Success in Europe

In this episode of PharmaTelevision News Review, Fintan Walton talks with Jordi Marti, CEO at Amgen Spain. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • Why Amgen decided to...

Kirin-Amgen JV To Become Wholly-owned Subsidiary Of Amgen

THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN) said that the company and Kirin Holdings (KNBWF.PK, KNBWY.PK) have agreed that Kirin-Amgen, a joint venture between the two companies, will redeem Kirin...

Kirin-Amgen Joint Venture To Become Wholly-Owned Subsidiary Of Amgen

$780 Million Payment to be Funded From Joint Venture's Existing Cash Holdings Kyowa Hakko Kirin to Continue as Licensee in Asia THOUSAND OAKS, Calif., Oct. 30, 2017 /PRNewswire/ -- Amgen (NASDAQ:AM...

Simcere to Market Four Amgen Biosimilars in China

Simcere Pharmaceutical of Nanjing struck a deal with Amgen to co-develop and commercialize four Amgen biosimilars in China. The exact biosimilars were not disclosed, though Amgen said they address nee...

Syngene expands Amgen collaboration as it recovers from fire incident

Syngene International is doubling the footprint of its research and development center following an expanded research collaboration with Amgen Inc. The Indian contract research organization inaugurate...

Amgen to buy Japanese joint venture

Amgen has entered an agreement to acquire Kirin-Amgen, its joint venture (JV) with Japan-based Kirin Holdings for $780m.

Amgen Announces 2017 Fourth Quarter Dividend

THOUSAND OAKS, Calif., Oct. 24, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that its Board of Directors declared a $1.15 per share dividend for the fourth quarter of 2017. The dividend ...

Amgen, Simcere pen biosimilars agreement in China

Amgen Inc. has teamed up with Simcere Pharmaceutical Group in an exclusive agreement to develop and commercialize in China four undisclosed Amgen biosimilars aimed at inflammation and cancer.

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Nplate [Amgen Inc]

These highlights do not include all the information needed to use Nplate safely and effectively. See full prescribing information for Nplate. Nplate (romiplostim)For subcutaneous injection Initial U.S...

Neulasta [AMGEN INC]

These highlights do not include all the information needed to use Neulasta safely and effectively. See full prescribing information for Neulasta. Neulasta (pegfilgrastim) injection, for subcutaneous u...

Neulasta [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use Neulasta safely and effectively. See full prescribing information for Neulasta.Neulasta (pegfilgrastim) injection, for subcutaneous us...

Sensipar [Amgen, Inc]

These highlights do not include all the information needed to use Sensipar safely and effectively. See full prescribing information for Sensipar. Sensipar (cinacalcet) TabletsInitial U.S. Approval: 20...

Xgeva [AMGEN]

These highlights do not include all the information needed to use XGEVA™ safely and effectively. See full prescribing information for XGEVA. Xgeva (denosumab)injection, for subcutaneous useInitial U...

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS.

The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on Biologics.

Letter--The Authors Respond.

None of the authors of this study are involved in financial or personal relationships with agencies, institutions, or organizations that inappropriately influenced the statistical analysis plan or int...

Patent trend and competitive analysis of cancer immunotherapy in the United States.

Immunotherapy has brought high hopes for cancer treatment, and attracted tremendous resources from the biopharmaceutical community. Here we analyze cancer immunotherapy-related patents granted by the ...

Accelerating Patient Access to Novel Biologics using Stable Pool-derived Product for Non-clinical Studies and Single Clone-derived Product for Clinical Studies.

Cell cloning and subsequent process development activities are on the critical path directly impacting the timeline for advancement of next generation therapies to patients with unmet medical needs. T...

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

The purpose of this study is to demonstrate therapeutic equivalence of subcutaneous (SC) Epoetin Hospira compared to SC Epogen (Amgen,) based on maintenance of hemoglobin (Hb) levels and s...

An Open Label Treatment Extension Study of AMG 706

This is an extension study to provide ongoing treatment with AMG 706 monotherapy for subjects with solid tumors who have completed the planned duration of AMG 706 treatment on a separate A...

Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

The purpose of this study is to assess the safety, tolerability, and utility of AMG 531 unit dosing (µg) in thrombocytopenic subjects with ITP.

Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation

The purpose of this study is to collect local laboratory data on immunoreactive parathyroid hormone (iPTH), calcium and phosphorus levels and estimated glomerular filtration rate (GFR) at ...

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

5-Drug Combination Chemotherapy with Hematologic Toxicity Attenuation. EPOCH: Etoposide, VP-16, NSC-141540; Prednisone, PRED, NSC-10023; Vincristine, VCR, NSC-67574; Cyclophosphamide, CTX...

Companies [45 Associated Companies listed on BioPortfolio]

Amgen, Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bri...

Amgen Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bri...

Amgen

The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live...

Amgen AB

Amgen är ett världsledande bioteknologiskt läkemedelsföretag. Genom vetenskapliga upptäckter och innovationer har företaget under 25 års tid bidragit till att radikalt förbättra människors l...

Amgen Inc

Amgen is a leading human therapeutics company in the biotechnology industry. For 25 years, the company has tapped the power of scientific discovery and innovation to dramatically improve people’s li...

More Information about "Amgen" on BioPortfolio

We have published hundreds of Amgen news stories on BioPortfolio along with dozens of Amgen Clinical Trials and PubMed Articles about Amgen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amgen Companies in our database. You can also find out about relevant Amgen Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record